Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists
This service is billed using CPT code 92002/92004
Half Life: 30 Hours
Eli Lilly is studying retatrutide in several phase-3 clinical trials for obesity, type-2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatosis liver disease
At Miami Bariatric and Plastic Surgery MD, we offer medically supervised CJC-1295 peptide therapy to help you safely reboot your natural hormone production, optimize your metabolism, and restore your youthful vitality from the inside out
Stay at least two inches away from your belly button